Neurocrine Biosciences, Prothena, Rent-A-Center Upgraded

Neurocrine Biosciences, Prothena, and Rent-A-Center stocks are on analysts' bullish radar today

Apr 12, 2017 at 9:30 AM
facebook X logo linkedin


Analysts are weighing in on drugmakers Neurocrine Biosciences, Inc. (NASDAQ:NBIX) and Prothena Corporation PLC (NASDAQ:PRTA), as well as retail stock Rent-A-Center. Here's a quick roundup of today's bullish brokerage notes on shares of NBIX and PRTA, as well as RCII stock.

Neurocrine Biosciences Signals FDA-Induced Bull Gap

NBIX stock is set to gap 22.2% higher at the open, after the Food and Drug Administration (FDA) approved the company's movement disorder drug, Ingrezza. Further bolstering the shares are price-target hikes at Leerink and Jefferies to $68 and $65, respectively -- both in record-high territory. This is more of the same from the brokerage crowd, as all 11 analysts covering Neurocrine Biosciences, Inc. rate it a "buy" or "strong buy." Yesterday, the stock settled at $41.48, up 7.2% year-to-date.

Prothena Secures Bullish Initiation

PRTA stock is pointed 1.3% higher ahead of the opening bell, lifted by an "overweight" initiation at Piper Jaffray -- which also set a price target of $69, in annual-high territory. Separately, Prothena Corporation PLC entered into a purchasing agreement with Boehringer Ingelheim. Taking a step back, it's been a rough month for PRTA shares, down 10.6% since the start of April. While shareholders can't be happy with the losses, plenty of short sellers are. Over 19% of the stock's float is sold short, which translates into 15 days' worth of trading, at PRTA's typical volumes.

Upgrade Could Extend RCII Stock's Recent Surge

RCII's week-to-date rally -- powered by Marcato Capital's call for a company sale -- looks like it will continue today. The stock is up 3.1% in electronic trading, after ending Tuesday at $10.48 -- having advanced 9.2% since last Friday's close. Stoking Rent-A-Center stock's bullish flames is an upgrade to "strong buy" from "market perform" at Raymond James. The shares' recent strength could be turning up the heat on short sellers. Nearly 20 million RCII shares are sold short, which would take two weeks to cover, based on the stock's average daily trading volume.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI